Unknown

Dataset Information

0

N6-methyladenine DNA Modification in Glioblastoma.


ABSTRACT: Genetic drivers of cancer can be dysregulated through epigenetic modifications of DNA. Although the critical role of DNA 5-methylcytosine (5mC) in the regulation of transcription is recognized, the functions of other non-canonical DNA modifications remain obscure. Here, we report the identification of novel N6-methyladenine (N6-mA) DNA modifications in human tissues and implicate this epigenetic mark in human disease, specifically the highly malignant brain cancer glioblastoma. Glioblastoma markedly upregulated N6-mA levels, which co-localized with heterochromatic histone modifications, predominantly H3K9me3. N6-mA levels were dynamically regulated by the DNA demethylase ALKBH1, depletion of which led to transcriptional silencing of oncogenic pathways through decreasing chromatin accessibility. Targeting the N6-mA regulator ALKBH1 in patient-derived human glioblastoma models inhibited tumor cell proliferation and extended the survival of tumor-bearing mice, supporting this novel DNA modification as a potential therapeutic target for glioblastoma. Collectively, our results uncover a novel epigenetic node in cancer through the DNA modification N6-mA.

SUBMITTER: Xie Q 

PROVIDER: S-EPMC6433469 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2018-11-01 | GSE118093 | GEO
2018-11-01 | GSE118092 | GEO
2018-11-01 | GSE117632 | GEO
| PRJNA484394 | ENA
| S-EPMC7185115 | biostudies-literature
2018-11-01 | GSE119081 | GEO
| S-EPMC6215013 | biostudies-literature
| S-EPMC8265677 | biostudies-literature
| PRJNA484396 | ENA
| PRJNA482757 | ENA